Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Ionis Pharmaceuticals (NASDAQ:IONS) Given Buy Rating at Needham & Company LLC

Summary by MarketBeat
Needham & Company LLC reaffirmed a "buy" rating and issued a $86.00 price target on shares of Ionis Pharmaceuticals in a research note on Friday.

1 Articles

MarketBeatMarketBeat
Center

Ionis Pharmaceuticals (NASDAQ:IONS) Given Buy Rating at Needham & Company LLC

Needham & Company LLC reaffirmed a "buy" rating and issued a $86.00 price target on shares of Ionis Pharmaceuticals in a research note on Friday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Friday, September 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Carlsbad, California icon

Carlsbad, California

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal